The week in industry: Expansion of the European medicinal cannabis market
This week: Helsinn Healthcare (Lugano, Switzerland) lose in patent case, Canopy Growth Corporation (OT, Canada) continue progress in their production and distribution of medical-cannabis in the UK and Poland, and the US FDA allows uniQure to begin their Phase I/II study.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>